Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada
Merck & Co., Inc., known as MSD outside the United States and Canada, is a leading global healthcare company headquartered in Rahway, New Jersey. Founded in 1891, Merck has established itself as a pioneer in the pharmaceutical industry, focusing on innovative medicines, vaccines, and animal health products. With a strong presence in North America, Europe, and emerging markets, Merck is renowned for its commitment to research and development, resulting in groundbreaking therapies in areas such as oncology, infectious diseases, and diabetes management. Notable products include the HPV vaccine Gardasil and the cancer treatment Keytruda, both of which have significantly impacted public health. Merck's dedication to scientific excellence and patient care has solidified its position as a trusted leader in the pharmaceutical sector, consistently achieving recognition for its contributions to global health.
DitchCarbon Score
How does Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada's score of 55 is higher than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada's reported carbon emissions
In 2023, Merck & Co., Inc., known as MSD outside the US and Canada, reported total carbon emissions of approximately 7,086,700,000 kg CO2e. This figure includes 718,400,000 kg CO2e from Scope 1 emissions, 184,200,000 kg CO2e from Scope 2 (market-based), and a significant 6,184,100,000 kg CO2e from Scope 3 emissions, which encompass the majority of their carbon footprint. Merck has set ambitious climate commitments, aiming to reduce operational greenhouse gas emissions (Scopes 1 and 2) by 46% by 2030, using a 2019 baseline. Additionally, the company targets a 30% reduction in its value chain emissions (Scope 3) by the same year. Looking further ahead, Merck is committed to achieving net-zero greenhouse gas emissions across all scopes by 2045, in alignment with the Science Based Targets initiative (SBTi). These initiatives reflect Merck's dedication to sustainability and its proactive approach to mitigating climate change impacts within the pharmaceutical industry.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 727,300,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 295,600,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 6,427,900,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merck And Co Inc Rahway Nj Usa Which Is Known As Msd Outside Us And Canada is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
